Pilot Study of BOTOX for Migraine Headaches
| Status: | Terminated |
|---|---|
| Conditions: | Migraine Headaches, Migraine Headaches |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/28/2018 |
| Start Date: | April 2004 |
| End Date: | April 2010 |
A Single-Center Pharmacoeconomic Pilot Study of BOTOX® (Botulinum Toxin Type A) for the Prophylactic Treatment of Migraine Headaches
The purposes of this study are to assess whether subjects treated with BOTOX will:
1. have a decrease in the frequency and intensity of migraine headaches
2. experience improvements in quality of life
3. experience a reduction in the frequency of health care services obtained.
1. have a decrease in the frequency and intensity of migraine headaches
2. experience improvements in quality of life
3. experience a reduction in the frequency of health care services obtained.
Inclusion Criteria:
- Subjects > 18 years of age
- Subject has an established history of migraine headache, with or without aura, per IHS
criteria (1.2.1 or 1.1), for at least 6 months prior to screening.
- Subject receives primary health care from Park Nicollet Health Services.
Exclusion Criteria:
- Subject has received previous injections of botulinum toxin of any serotype for any
reason, within the 6 months prior to study participation.
Additional eligibility will be discussed at point of contact
We found this trial at
1
site
Click here to add this to my saved trials
